Dr Phillip Pymm
Honorary (Fellow)
Department of Medical Biology (WEHI)
35 Scholarly works
0 Projects
HIGHLIGHTS
2026
Journal article
Alpseq: an open-source workflow to turbocharge nanobody discovery with high-throughput sequencing
DOI: 10.1080/19420862.2026.26233262026
Journal article
Crystal structure and nanobodies against domain 3 of the malaria parasite fusogen Plasmodium falciparum HAP2
DOI: 10.1042/BCJ202502972026
Journal article
Elevated SARS-CoV-2 IgG4 in plasma and mucosa following repeated mRNA boosters impact antibody functions to Omicron and sarbecoviruses
DOI: 10.1016/j.ebiom.2025.1060872025
Journal article
Potent neutralising monoclonal antibodies targeting the spike of NL63 coronavirus
DOI: 10.1038/s44298-025-00116-x2025
Journal article
A novel chimeric coronavirus spike vaccine combining SARS-CoV-2 RBD and scaffold domains from HKU-1 elicits potent neutralising antibody responses
DOI: 10.1038/s41541-025-01323-62025
Journal article
Prediction of KIR3DL1 and human leukocyte antigen binding
DOI: 10.1016/j.jbc.2025.1104372025
Journal article
Stabilized designs of the malaria adhesin protein PvRBP2b for use as a potential diagnostic for Plasmodium vivax[Figure presented]
DOI: 10.1016/j.jbc.2025.108290
RECENT SCHOLARLY WORKS
2024
Journal article
The Structural Basis for Recognition of Human Leukocyte Antigen Class I Molecules by the Pan-HLA Antibody W6/32
DOI: 10.4049/jimmunol.24003282024
Journal article
Correction to: A placental model of SARS-CoV-2 infection reveals ACE2-dependent susceptibility and differentiation impairment in syncytiotrophoblasts (Nature Cell Biology, (2023), 25, 8, (1223-1234), 10.1038/s41556-023-01182-0)
DOI: 10.1038/s41556-023-01335-12024
Journal article
Human coronavirus OC43 nanobody neutralizes virus and protects mice from infection
DOI: 10.1128/jvi.00531-24